1st Quarter - Report

AMERICAN ACADEMY OF NEUROLOGY for AMERICAN ACADEMY OF NEUROLOGY

Firm
Client
Income
—
Expenses
$370,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Strengthening the VA Centers of Excellence

LobbyistCovered position, as disclosed
DEREK CHRISTOPHER BRANDT —

Contacted: SENATE; Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

H.R. 88; Section 505: Repeal of Unrelated Business Income Tax on Qualified Transportation Fringe Benefits

LobbyistCovered position, as disclosed
DEREK CHRISTOPHER BRANDT —

Contacted: Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 88 (116th)

Health Issues HCR

S. 61 / H.R. 478: Safe and Affordable Drugs from Canada Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 97 / H.R. 447: Affordable and Safe Prescription Drug Importation Act S. 350/H.R. 1418: Competitive Health Insurance Reform Act of 2019 H.R. 171: Legitimate Use of Medicinal Marijuana Act H.R. 1585: Violence Against Women Reauthorization Act of 2019 H.R. 2279: Safe Step Act PCORI Reauthorization; Eliminating DTC prescription pharmaceutical CDC funding for research into firearm morbidity and mortality prevention; Policy to address surprised medical billing; Promoting interoperability in electronic health records; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues; loan repayment for pediatric specialists.

LobbyistCovered position, as disclosed
DEREK CHRISTOPHER BRANDT —
AMY KALOIDES New Legislative Aid, Sen. Mark Dayton.
MATTHEW ROSS KERSCHNER New —
NATALIE PONTZER New —
ANDREW SCHWAB New —

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 447 (116th), H.R. 1585 (116th), S. 61 (116th), H.R. 478 (116th), H.R. 2279 (116th), S. 97 (116th), H.R. 171 (116th), S. 350 (116th), S. 73 (116th), H.R. 1418 (116th)

Medicare/Medicaid MMM

S. 62: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 348/H.R. 1763: The Resident Physician Shortage Reduction Act of 2019 S. 560/H.R. 1379: the Ensuring Lasting Smiles Act S. 966/ H.R. 2282: Medicare Care Coordination Improvement Act H.R. 275: Medicare Prescription Drug Price Negotiation Act of 2019 Valuation of Long-term Electroencephalogram monitoring; Issues associated with Qualified Clinical Data Registry implementation, measure licensing, approval, removal, benchmarking, and revision; Eliminating or streamlining requirements for prior authorization or step therapy; CMS proposed rule altering Evaluation and Management billing codes; appropriate use criteria for imaging services; Medicare coverage of oxygen therapy for cluster headaches.

LobbyistCovered position, as disclosed
DEREK CHRISTOPHER BRANDT —
AMY KALOIDES New Legislative Aid, Sen. Mark Dayton.
MATTHEW ROSS KERSCHNER New —
NATALIE PONTZER New —
ANDREW SCHWAB New —

Contacted: Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1379 (116th), S. 966 (116th), H.R. 2282 (116th), S. 560 (116th), S. 62 (116th), H.R. 1763 (116th), S. 348 (116th), H.R. 275 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.